Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vita Coco Company (COCO) Accumulated Expenses (2020 - 2026)

Vita Coco Company (COCO) has disclosed Accumulated Expenses for 7 consecutive years, with $97.4 million as the latest value for Q1 2026.

  • For Q1 2026, Accumulated Expenses rose 44.2% year-over-year to $97.4 million; the TTM value through Mar 2026 reached $97.4 million, up 44.2%, while the annual FY2025 figure was $89.5 million, 36.37% up from the prior year.
  • Accumulated Expenses hit $97.4 million in Q1 2026 for Vita Coco Company, up from $89.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $99.8 million in Q3 2025 and bottomed at $35.7 million in Q1 2022.
  • Average Accumulated Expenses over 5 years is $62.3 million, with a median of $59.5 million recorded in 2023.
  • Year-over-year, Accumulated Expenses decreased 10.67% in 2022 and then surged 55.27% in 2023.
  • Vita Coco Company's Accumulated Expenses stood at $38.3 million in 2022, then soared by 55.27% to $59.5 million in 2023, then rose by 10.2% to $65.6 million in 2024, then skyrocketed by 36.37% to $89.5 million in 2025, then grew by 8.92% to $97.4 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $97.4 million, $89.5 million, and $99.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.